Literature DB >> 30943057

Beam direction arrangement using a superconducting rotating gantry in carbon ion treatment for pancreatic cancer.

Woong Sub Koom1,2, Shinichiro Mori2, Wataru Furuich3, Shigeru Yamada2.   

Abstract

OBJECTIVES: Carbon ion radiotherapy provides a concentrated dose distribution to the target and has several advantages over photon radiotherapy. This study aimed to evaluate the optimal beam direction in carbon ion pencil beam scanning and compare dose distributions between the rotating gantry system (RGS) and fixed-beam port system (FBPS).
METHODS: Patients with locally advanced pancreatic cancer were randomly selected. First, dose-volume parameters of 7-beam directions in the prone position were evaluated. Second, a composite plan developed using 4-beam directions in RGS was compared with that developed using FBPS, with a total prescribed dose of 55.2 Gy (relative biological effectiveness, RBE) in 12 fractions.
RESULTS: Target coverages in the composite plan did not widely differ. For the first and second segments of the duodenum, the mean dose of D2cc was not significantly changed (23.80 ± 11.90 Gy [RBE] and 25.63 ± 10.41 Gy [RBE] for RGS and FBPS, respectively). However, the dose-volume histogram curve in RGS showed a prominent dose reduction in the low-dose region. No significant differences were observed in the stomach, third and fourth segments of the duodenum, and spinal cord. The mean dose of the total kidney was similar between RGS and FBPS.
CONCLUSIONS: Compared with that of FBPS, the 4-beam arrangement in the prone position using RGS provides comparable or superior dose distribution in the surrounding normal organ while achieving the same target coverage. In addition, RGS allows for single-patient positioning. ADVANCES IN KNOWLEDGE: RGS is beneficial in delivering radiotherapy doses to the duodenum and allows for single-patient positioning and a simple planning process.

Entities:  

Mesh:

Year:  2019        PMID: 30943057      PMCID: PMC6592073          DOI: 10.1259/bjr.20190101

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

1.  A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning.

Authors:  Nobuyuki Kanematsu; Naruhiro Matsufuji; Ryosuke Kohno; Shinichi Minohara; Tatsuaki Kanai
Journal:  Phys Med Biol       Date:  2003-04-21       Impact factor: 3.609

2.  The Heidelberg Ion Therapy Center.

Authors:  T h Haberer; J Debus; H Eickhoff; O Jäkel; D Schulz-Ertner; U Weber
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

Review 3.  Current status and new developments in ion therapy.

Authors:  Christian P Karger; Oliver Jäkel
Journal:  Strahlenther Onkol       Date:  2007-06       Impact factor: 3.621

4.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

5.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

6.  Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy.

Authors:  T Kanai; M Endo; S Minohara; N Miyahara; H Koyama-ito; H Tomura; N Matsufuji; Y Futami; A Fukumura; T Hiraoka; Y Furusawa; K Ando; M Suzuki; F Soga; K Kawachi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

7.  Pancreatic tumors show high levels of hypoxia.

Authors:  A C Koong; V K Mehta; Q T Le; G A Fisher; D J Terris; J M Brown; A J Bastidas; M Vierra
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

8.  Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; James S Tomlinson; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

9.  Impact of intrafractional bowel gas movement on carbon ion beam dose distribution in pancreatic radiotherapy.

Authors:  Motoki Kumagai; Ryusuke Hara; Shinichiro Mori; Takeshi Yanagi; Hiroshi Asakura; Riwa Kishimoto; Hirotoshi Kato; Shigeru Yamada; Susumu Kandatsu; Tadashi Kamada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

10.  Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.

Authors:  Kevin R Kozak; Lisa A Kachnic; Judith Adams; Elizabeth M Crowley; Brian M Alexander; Harvey J Mamon; Carlos Fernandez-Del Castillo; David P Ryan; Thomas F DeLaney; Theodore S Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-04       Impact factor: 7.038

View more
  2 in total

1.  Fixed Beamline Optimization for Intensity Modulated Carbon-Ion Therapy.

Authors:  Pavitra Ramesh; Hengjie Liu; Wenbo Gu; Ke Sheng
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-06-25

2.  Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.

Authors:  Yang Li; Yoshiki Kubota; Masahiko Okamoto; Shintaro Shiba; Shohei Okazaki; Toshiaki Matsui; Mutsumi Tashiro; Takashi Nakano; Tatsuya Ohno
Journal:  Radiat Oncol       Date:  2021-06-19       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.